For US residents only.

 Visit Health Care Professional Site

I'm looking for:
  • Financial Assistance
    • Financial Assistance Home
    • Health Care Education
    • Private Insurance
    • No Insurance
    • Government Insurance
  • Support
    • Help & Support Home
    • Support Resources
    • Our Commitment to Patients
    • Novartis Products

Novartis Oncology Universal Co-pay Program

In order to enroll in this program, please select your medication, read the Terms and Conditions carefully and answer the questions below.

Select Medication
Full Prescribing Information
Full Prescribing Information
Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
Patients are responsible for the first $10 co-pay for a 30-day supply and Novartis will pay up to $10,630 per 30-day supply up to $30,000 per calendar year. If patient reaches the maximum annual cap per calendar year of $30,000, patient will be responsible for the difference.
This offer is available for patients with a prescription for KISQALI, a prescription for FEMARA (including generic letrozole), a prescription for both products, or a prescription for the KISQALI/FEMARA Co-Pack. Use of the offer for FEMARA (or generic letrozole) does not require a KISQALI prescription.
For purchases of FEMARA only, this offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.

Are you taking SANDOSTATIN for an approved use, consistent with the product's prescribing information (see link above)?
You are not eligible for this co-pay program. For more information, please call Novartis at 1-877-577-7756.
Patient eligibility certification and enrollment
In order to proceed with enrollment, please complete the eligibility certification above.
Please enter patient information
*Required
Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria. For purchases of FEMARA only, this offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria. Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria. Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria. Offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
At least 1 phone number is required*
Home phone number is required
Patient must be 18 years and over to be enrolled
Primary Insurance Prior Authorization Start Date is not valid Primary Insurance Prior Authorization Start Date is greater than End Date
Primary Insurance Prior Authorization End Date is not valid
Telephone Consumer Protection Act (TCPA) Consent (Optional)
Voicemail Consent (Optional)
Patient is not eligible. 1 voucher per life of the program.

If you have an existing co-pay card and need to let us know about an insurance change, or if any personal information associated with the card has changed (such as your name or address), please call 1-877-577-7756.
Terms and Conditions:
The Novartis Oncology Universal Co-pay Program includes the co-pay card, payment card, or rebate with a combined annual limit of $15,000. Patient is responsible for any costs once the limit is reached in a calendar year.
  • This offer is only available to patients with private insurance. The program is not available for patients who: (i) are enrolled in Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program; (ii) are not using insurance coverage at all; (iii) are enrolled in an insurance plan that reimburses for the entire cost of the drug; or (iv) where product is not covered by patient's insurance.
  • The value of this program is exclusively for the benefit of enrolled patients and is intended to be credited toward patient out-of-pocket obligations, including applicable copayments, coinsurance, and deductibles.
  • Proof of purchase may be required.
  • Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account.
  • Patient is responsible for complying with any applicable limitations and requirements of his/her health plan related to the use of the program.
  • Program is not valid where prohibited by law. Valid only in the United States and Puerto Rico. For certain medications, this offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
  • This program is not health insurance. This program may not be combined with any third-party rebate, coupon, or offer.
  • Novartis reserves the right to rescind, revoke, or amend the program and discontinue support at any time without notice.
Patient Instructions: After enrollment in the program, present this card and your insurance card along with a valid prescription at any participating pharmacy or through mail order. Patients are responsible for up to the first $25 (specific offer varies by brand) and Novartis pays up to $15,000 per calendar year. If patient reaches the maximum annual cap per calendar year of $15,000, patient will be responsible for the difference.
When you use this card, you are certifying that you understand and agree to comply with the program Terms and Conditions above.
Direct patient questions to: 1-877-577-7756.
Terms and Conditions:
The Novartis Oncology Universal Co-pay Program includes the co-pay card, payment card, or rebate with a combined annual limit of $15,000. Patient is responsible for any costs once the limit is reached in a calendar year.
  • This offer is only available to patients with private insurance. The program is not available for patients who: (i) are enrolled in Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program; (ii) are not using insurance coverage at all; (iii) are enrolled in an insurance plan that reimburses for the entire cost of the drug; or (iv) where product is not covered by patient’s insurance.
  • The value of this program is exclusively for the benefit of enrolled patients and is intended to be credited toward patient out-of-pocket obligations, including applicable copayments, coinsurance, and deductibles.
  • Proof of purchase may be required.
  • Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account.
  • Patient is responsible for complying with any applicable limitations and requirements of his/her health plan related to the use of the program.
  • Program is not valid where prohibited by law. Valid only in the United States and Puerto Rico. For certain medications, this offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria.
  • This program is not health insurance. This program may not be combined with any third-party rebate, coupon, or offer.
  • Novartis reserves the right to rescind, revoke, or amend the program and discontinue support at any time without notice.
Close
TCPA Terms and Conditions
By signing up to receive marketing texts and calls, or by requesting information by telephone, text message, fax, email, direct mail or other means, you accept, without limitation or qualification, that:
  • You and Novartis agree that any legal disputes or claims arising out of or related to the Terms and Conditions, or the use of the Novartis products and/or the Services (including but not limited to telephone calls or text messages sent by Novartis), or the interpretation, enforceability, revocability or validity of the Terms and Conditions, or the arbitrability of any dispute), that cannot be resolved informally shall be submitted to binding arbitration in the state in which the Terms and Conditions was performed. The arbitration shall be conducted by the American Arbitration Association under its Commercial Arbitration Rules.
  • This arbitration clause is an independent agreement and shall survive the termination and/or transfer of these Terms and Conditions or any other agreement between you and Novartis. If any provision of the agreement to arbitrate in this Section 6 is found unenforceable, the unenforceable provision will be severed and the remaining arbitration terms will be enforced (but in no case will there be a class, representative or private attorney general arbitration). Any judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. Claims shall be brought within the time required by applicable law. The laws of the State of New York will govern the Terms and Conditions and the Federal Arbitration Act, 9 U.S.C. §§ 1-16, will govern this Section 6, without giving effect to any principles of conflicts of laws. Each party shall bear its own costs relating to the arbitration consistent with the Commercial Arbitration Rules of the American Arbitration Association.
  • You and Novartis agree that any claim, action or proceeding arising out of or related to the Terms and Conditions or telephone calls or text messages sent by Novartis must be brought in your individual capacity, and not as a plaintiff or class member in any purported class, collective or representative proceeding. The arbitrator may not consolidate more than one person's claims, and the arbitrator may not otherwise preside over any form of a representative, collective or class proceeding.
YOU ACKNOWLEDGE AND AGREE THAT YOU AND NOVARTIS ARE EACH WAIVING THE RIGHT TO A TRIAL BY JURY OR TO PARTICIPATE AS A PLAINTIFF OR CLASS MEMBER IN ANY PURPORTED CLASS ACTION OR REPRESENTATIVE PROCEEDING.
Close
*Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $15,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient's insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient's insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. For purchases of FEMARA only, this offer is NOT valid for Massachusetts patients and is only valid for California patients that meet additional eligibility criteria. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
Close
*Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $15,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient's insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient's insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.
Close

Contact Us Non-US Residents

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2024 Novartis Pharmaceuticals Corporation. All rights reserved.

Use of website is governed by the Terms of Use and Privacy Policy.

Copyright © 2024 Novartis Pharmaceuticals Corporation.

All rights reserved.

7/24 FA-11229060